The New Mexico State Investment Council approved allocations across two real estate funds and a single real return offering at its latest November meeting.
The $30 billion portfolio includes a 10% target allocation or $3 billion to real estate investments. Trustees approved two new mandates -- Blackstone BioMed Life Science Real Estate ($50 million) and KKR Real Estate Partners America III ($75 million).
The Blackstone commitment would be comprised of $25 million from existing exposure to BioMed through Blackstone Real Estate Partners VIII and an additional $25 million commitment. BioMed is the second largest owner of . . .
Unlock this article instantly, along with the rest of our premium content and daily, weekly and monthly newsletters. We offer pay-as-you-go monthly subscriptions and discounted annual subscriptions with additional benefits: access to Alternatives Watch Research articles and our Annual Investor Compendium.